PUBLISHER: The Business Research Company | PRODUCT CODE: 1938708
PUBLISHER: The Business Research Company | PRODUCT CODE: 1938708
The term veterinary anti-infective encompasses a wide range of methods aimed at preventing and treating illnesses in animals. These products are utilized in veterinary medicine to promote the health and well-being of both livestock and pets, as well as to control disease outbreaks within animal populations.
The main types of drug classes in veterinary anti-infectives include antimicrobial agents, antiviral agents, antifungal agents, and others. Antimicrobial agents are substances, either natural or synthetic, that function by killing or inhibiting the growth of microorganisms such as bacteria, fungi, and algae. Various species, including livestock animals and companion animals, are involved in the administration of these drugs through oral, parenteral, and topical modes. Distribution channels for veterinary anti-infectives include veterinary hospitals, veterinary clinics, pharmacies, and other relevant outlets.
Tariffs have affected the veterinary anti-infectives market by increasing the cost of imported drugs, vaccines, and medical equipment, particularly in regions like north america and europe. Segments such as antimicrobial agents, antiviral agents, and antifungal agents are most impacted due to reliance on imported raw materials and formulations. Positive impacts include incentivizing domestic production, fostering local R&D in veterinary drugs, and encouraging innovation in cost-effective anti-infective solutions.
The veterinary anti-infectives market research report is one of a series of new reports from The Business Research Company that provides veterinary anti-infectives market statistics, including veterinary anti-infectives industry global market size, regional shares, competitors with a veterinary anti-infectives market share, detailed veterinary anti-infectives market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary anti-infectives industry. This veterinary anti-infectives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The veterinary anti-infectives market size has grown strongly in recent years. It will grow from $6.02 billion in 2025 to $6.59 billion in 2026 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to rising prevalence of livestock diseases, growing companion animal population, traditional reliance on antibiotics, increasing veterinary awareness, expansion of veterinary clinics in asia-pacific.
The veterinary anti-infectives market size is expected to see strong growth in the next few years. It will grow to $9.53 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to rising demand for precision veterinary medicines, growing adoption of antiviral and antifungal agents, increasing focus on preventive healthcare, expansion of veterinary hospitals and pharmacies, development of immune modulators and advanced disinfectants. Major trends in the forecast period include increasing use of antibiotics and antimicrobial agents, rising adoption of vaccines and antiviral medications, growing awareness of animal disease prevention, expansion of companion animal healthcare market, rising demand for topical and systemic antifungal treatments.
The growth in pet ownership is expected to drive the expansion of the veterinary anti-infectives market going forward. Pet ownership refers to having a dog, cat, or other domestic animal as a household companion. Pet adoption is increasing as a growing share of the younger population considers pets to be part of the family, while others adopt pets for companionship, loyalty, and to reduce feelings of loneliness. Veterinary anti-infectives support pet ownership by preventing and treating infections in animals, helping maintain pet health and lowering the risk of disease transmission to both pets and owners. For example, in 2023, according to Shelter Animals Count, a US-based non-governmental organization, approximately 177,000 additional dogs and cats entered the animal sheltering system nationwide compared with the same period in 2022. Therefore, the rise in pet ownership is driving demand for the veterinary anti-infectives market.
Leading companies operating in the veterinary anti-infectives market are leveraging advanced technologies to maintain and strengthen their market position. Advanced technologies include innovative tools and methods that enhance the prevention, diagnosis, and treatment of animal infections, improving both effectiveness and safety. For instance, in May 2025, Amazon.com Inc., a US-based e-commerce and pharmacy services provider, expanded its pet prescription medication offerings through a partnership with Strategic Pharmaceutical Solutions Inc. (Vetsource), a US-based veterinary technology and pharmacy platform. This initiative enables customers to order veterinarian-approved anti-infectives and other prescriptions online, with delivery typically within two to six days, and streamlines refill approvals through digital checkout integration and veterinarian verification. This approach broadens access and improves customer engagement, while requiring careful alignment with clinical workflows and regulatory requirements.
In April 2024, Virbac S.A., a France-based supplier of veterinary pharmaceuticals, vaccines, anti-infectives, and animal health products for companion animals and livestock, acquired Sasaeah Pharmaceutical Co. Ltd. for an undisclosed amount. Through this acquisition, Virbac expanded its geographic presence and strengthened its veterinary anti-infectives and broader pharmaceutical portfolio, particularly within the cattle segment, by leveraging Sasaeah's established manufacturing and research and development capabilities in Japan and Vietnam. Sasaeah Pharmaceutical Co. Ltd. is a Japan-based provider of veterinary health products, including vaccines, anti-infectives, and pharmaceutical treatments across major animal species, reinforcing Virbac's competitive position in the global veterinary anti-infectives market.
Major companies operating in the veterinary anti-infectives market are Bayer AG, C. H. Boehringer Sohn AG & Co. KG, Ceva Sante Animale, Elanco Animal Health Incorporated, Zoetis Inc., Vetoquinol S. A., Merck & Co., Phibro Animal Health, Aspen Veterinary Resources Ltd., Bimeda Animal Health Limited, Dechra Pharmaceuticals Plc, Intervet International B. V., Oceanic Pharmachem Pvt. Ltd., Virbac Ltd., Indian Immunologicals Ltd. (IIL), Norbrook Laboratories Ltd., Ashish Life Science Pvt. Ltd., Kyoritsu Seiyaku Corporation, Tianjin Ringpu Bio-Technology Co. Ltd., HIPRA, Zydus Animal Health and Investments Limited, China Animal Husbandry Group, ZOOVETVARU Ltd., Magnum Veterinaaria Ltd., Inovet (V. M. D. nv/sa), Chanelle Pharmaceuticals Manufacturing Ltd., Huvepharma Inc., Veyx Pharma GmbH, Biovet Pvt. Ltd., Laboratorios Ovejero SA, Laboratorios Syva S. A.
North America was the largest region in the veterinary anti-infectives market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary anti-infectives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the veterinary anti-infectives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The veterinary anti-infectives market consists of revenues earned by entities by providing antibacterial that are used to prevent and treat animal diseases such as infections. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Veterinary Anti-infectives Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses veterinary anti-infectives market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for veterinary anti-infectives ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary anti-infectives market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.